Amgen Q2 Adj EPS $5.00 Beats $4.44 Estimate, Sales $6.99B Beat $6.63B Estimate
Portfolio Pulse from Benzinga Newsdesk
Amgen reported Q2 adjusted earnings of $5.00 per share, beating the analyst consensus estimate of $4.44 by 12.61%. This is a 7.53% increase from the same period last year. The company also reported quarterly sales of $6.99 billion, beating the analyst consensus estimate of $6.63 billion by 5.37%, a 5.94% increase from the same period last year.
August 04, 2023 | 2:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amgen's Q2 earnings and sales exceeded analyst estimates, indicating a strong financial performance.
Amgen's better-than-expected Q2 earnings and sales indicate a strong financial performance, which is likely to positively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100